Revenue: The sum of all revenue fields included for a company's operating activities.
Tvardi Therapeutics, Inc. (TVRD) had Revenue of $2.57M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$2.57M |
$-4.91M |
|
-- |
|
$2.57M |
|
$4.96M |
|
$-2.39M |
|
$-2.52M |
|
$-4.91M |
|
$-4.91M |
|
$-4.91M |
|
$-4.91M |
|
$-4.91M |
|
$-4.91M |
|
$-2.39M |
|
$-2.39M |
|
1.52M |
|
1.52M |
|
$-3.22 |
|
$-3.22 |
|
| Balance Sheet Financials | |
$38.95M |
|
-- |
|
-- |
|
$38.95M |
|
$1.20M |
|
-- |
|
$45.82M |
|
$47.02M |
|
$-8.07M |
|
$-8.07M |
|
$-8.07M |
|
1.52M |
|
| Cash Flow Statement Financials | |
$-4.69M |
|
-- |
|
$1.01M |
|
$37.90M |
|
$34.22M |
|
$-3.69M |
|
$1.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
32.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-92.88% |
|
-92.88% |
|
-- |
|
-190.97% |
|
-190.97% |
|
$-4.69M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
1.15 |
|
78.40 |
|
60.77% |
|
60.77% |
|
-12.60% |
|
60.77% |
|
$-5.29 |
|
$-3.08 |
|
$-3.08 |
|